Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07389018 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study to Evaluate the Feasibility of Syde® Digital Endpoints for Monitoring Patients With Progressive Supranuclear Palsy - Richardson Syndrome (PSP-R)

Study acronym: PROSPER-SYDE
StatusNot Yet Recruiting
PhaseNot specified
SponsorSYSNAV
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Mar 2026 to May 2026
    • Primary and study completion pushed from Jan 2028 to Mar 2028
    v4
  2. Re-verified, no change to tracked fieldsv3
  3. Primary endpoints revised (2)v2 Show 4 more changesShow less
    • Primary and study completion dates: Dec 2027 to Jan 2028
    • Start date: Feb 2026 to Mar 2026
    • Secondary endpoints revised (10)
    • Study title shortened, about 3 words
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
SYSNAV
4 trials monitored
See 1 trial at risk
The study aims to assess the feasibility/acceptability of real-world activity monitoring by the Syde® wearable device in PSP-R. The Syde® collected data will be compared to on-site conventional clinical endpoints, including functional capacity and cognitive assessments, as well as core scales assessments.
Trial Details
NCT Number NCT07389018
Lead Sponsor SYSNAV
Conditions
(from sponsor)		 Progressive Supranuclear Palsy- Richardson Syndrome (PSP-R)
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov